BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases ...

Source: BMC Cancer - May 16, 2018 Category: Cancer & Oncology Authors: David Pasquier, Emilie Bogart, Fran çois Bonodeau, Thomas Lacornerie, Eric Lartigau and Igor Latorzeff Tags: Study protocol Source Type: research